PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-933.36%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-933.36%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-1137.19%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-1163.64%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-1163.64%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-66.98%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-66.98%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
85.06%
OCF/share CAGR of 85.06% while CRON.TO is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
85.06%
OCF/share CAGR of 85.06% while CRON.TO is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
85.06%
3Y OCF/share CAGR of 85.06% while CRON.TO is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
46.58%
10Y net income/share CAGR of 46.58% while CRON.TO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
46.58%
Net income/share CAGR of 46.58% while CRON.TO is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
46.58%
3Y net income/share CAGR of 46.58% while CRON.TO is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
-56.80%
Negative equity/share CAGR over 10 years while CRON.TO stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-56.80%
Negative 5Y equity/share growth while CRON.TO is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-56.80%
Negative 3Y equity/share growth while CRON.TO is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.52%
Firm’s AR is declining while CRON.TO shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-9.38%
Negative asset growth while CRON.TO invests at 181.68%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-22.07%
We have a declining book value while CRON.TO shows 394.50%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
933.35%
SG&A growth well above CRON.TO's 697.61%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.